|
2022
|
P/S
|
biological preparations for use in industry and science in the nature of exosomes for scientific,... |
|
|
P/S
|
Exosomes for scientific, laboratory or medical research. Exosomes for medical or clinical use. |
|
|
Invention
|
Gpi anchored proteins and extracellular vesicles comprising them.
The present invention provides... |
|
|
Invention
|
Gpi anchored proteins and extracellular vesicles comprising them. The present invention provides ... |
|
2021
|
Invention
|
Induced pluripotent cell comprising a controllable transgene for conditional immortalisation.
Th... |
|
|
Invention
|
Induced pluripotent cell comprising a controllable transgene for conditional immortalisation. The... |
|
2020
|
Invention
|
Nucleic acid constructs for delivering polynucleotides into exosomes.
The invention delivers exo... |
|
|
Invention
|
Nucleic acid constructs for delivering polynucleotides into exosomes. The invention delivers exog... |
|
|
Invention
|
Genetic modification site.
This invention relates to genetic engineering, in particular to an in... |
|
|
Invention
|
Genetic modification site. This invention relates to genetic engineering, in particular to an ins... |
|
2019
|
Invention
|
Induced pluripotent cell comprising a controllable transgene for conditional immortalization.
Th... |
|
|
Invention
|
Stem cell microparticles.
This invention relates to stem cell microparticles, their use and prod... |
|
|
Invention
|
Stem cell microparticles and mirna.
This invention relates to stem cell microparticles and miRNA... |
|
2018
|
Invention
|
Neural stem cell therapy for stroke.
The invention relates to the treatment of stroke using neur... |
|
|
Invention
|
Stem cell microparticles for cancer therapy. The present invention relates to neural stem cell pa... |
|
2014
|
Invention
|
Stem cell microparticles and mirna. This invention relates to stem cell microparticles and miRNA ... |
|
|
Invention
|
Microparticles, mirna and wound therapy. This invention relates to wound care products comprising... |
|
|
Invention
|
Treatment of limb ischemia. The present invention uses neural stem cells in the manufacture of a ... |
|
|
Invention
|
Method of producing microparticles.
The invention is based on the finding that microparticles ca... |
|
|
Invention
|
Method of producing microparticles. The invention is based on the finding that microparticles can... |
|
2013
|
Invention
|
Stem cell microparticles. This invention relates to stem cell microparticles, their use and produ... |
|
2012
|
Invention
|
Methods of treating stroke through administration of ctx0e03 cells.
The subject invention pertai... |
|
2011
|
Invention
|
Therapeutic use of neural stem cells. The present invention provides an isolated cell obtainable ... |
|
2009
|
Invention
|
Cellular compositions for use in therapy.
wherein the composition does not comprise a dipolar ap... |
|
|
Invention
|
Cellular compositions for use in therapy. The present invention provides a therapeutic compositio... |
|
2008
|
Invention
|
Cell lines. The present invention relates to cells obtainable from cell lines having the ECACC Ac... |
|
2007
|
P/S
|
Cells for scientific, laboratory and medical research; human cells for scientific, laboratory and... |
|
2006
|
P/S
|
Stem cells; neural stem cells; somatic stem cells; cell lines; stem cell products; stem cell comb... |
|
|
Invention
|
Conditionally-immortalised pancreatic cells.
Conditionally immortalized pancreatic cells are pro... |
|
|
Invention
|
Conditionally-immortalised pancreatic cells. Conditionally immortalized pancreatic cells are prod... |
|
2005
|
Invention
|
Cell lines. Genomic instability in T-antigen expressing cells can be overcome by modifying the ge... |
|
|
Invention
|
Mycer immortalized hepatocyte. The invention relates to the production of hepatocyte cell lines u... |
|
|
Invention
|
Neural transplantation using pluripotent neuroepithelial cells. The subject invention pertains to... |
|
2004
|
Invention
|
Immortalisation of mammalian cells and therapeutic applications of said cells. Genomic instabilit... |
|
2003
|
Invention
|
Treatment of brain damage. The present invention relates to the treatment of brain damage by cell... |
|
2002
|
Invention
|
Promoters to control cell differentiation.
Recombinant vectors or constructs are prepared compri... |
|
|
Invention
|
Promoters to control cell differentiation. Recombinant vectors or constructs are prepared compris... |
|
|
Invention
|
Identification of cells for transplantation. Pluripotent cells that are suitable for transplantat... |
|
2000
|
Invention
|
Conditional immortalization of cells. A recombinant, or genetically engineered, mammalian cell, c... |
